189 related articles for article (PubMed ID: 9052397)
21. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
[TBL] [Abstract][Full Text] [Related]
22. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
Gabizon A; Catane R; Uziely B; Kaufman B; Safra T; Cohen R; Martin F; Huang A; Barenholz Y
Cancer Res; 1994 Feb; 54(4):987-92. PubMed ID: 8313389
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model.
Cabanes A; Tzemach D; Goren D; Horowitz AT; Gabizon A
Clin Cancer Res; 1998 Feb; 4(2):499-505. PubMed ID: 9516942
[TBL] [Abstract][Full Text] [Related]
25. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy.
Ning S; Macleod K; Abra RM; Huang AH; Hahn GM
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):827-34. PubMed ID: 8040030
[TBL] [Abstract][Full Text] [Related]
26. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
Allen TM; Mumbengegwi DR; Charrois GJ
Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
[TBL] [Abstract][Full Text] [Related]
27. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
[TBL] [Abstract][Full Text] [Related]
28. Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts.
Sakakibara T; Chen FA; Kida H; Kunieda K; Cuenca RE; Martin FJ; Bankert RB
Cancer Res; 1996 Aug; 56(16):3743-6. PubMed ID: 8706018
[TBL] [Abstract][Full Text] [Related]
29. Heparosan-coated liposomes for drug delivery.
Lane RS; Haller FM; Chavaroche AAE; Almond A; DeAngelis PL
Glycobiology; 2017 Nov; 27(11):1062-1074. PubMed ID: 29044377
[TBL] [Abstract][Full Text] [Related]
30. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma.
Coukell AJ; Spencer CM
Drugs; 1997 Mar; 53(3):520-38. PubMed ID: 9074848
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy.
Siegal T; Horowitz A; Gabizon A
J Neurosurg; 1995 Dec; 83(6):1029-37. PubMed ID: 7490617
[TBL] [Abstract][Full Text] [Related]
32. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.
Laverman P; Carstens MG; Boerman OC; Dams ET; Oyen WJ; van Rooijen N; Corstens FH; Storm G
J Pharmacol Exp Ther; 2001 Aug; 298(2):607-12. PubMed ID: 11454922
[TBL] [Abstract][Full Text] [Related]
33. Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery.
Park JH; Cho HJ; Yoon HY; Yoon IS; Ko SH; Shim JS; Cho JH; Park JH; Kim K; Kwon IC; Kim DD
J Control Release; 2014 Jan; 174():98-108. PubMed ID: 24280260
[TBL] [Abstract][Full Text] [Related]
34. Liver metastases from colorectal cancer: drug delivery with liposome-encapsulated doxorubicin.
Cay O; Kruskal JB; Nasser I; Thomas P; Clouse ME
Radiology; 1997 Oct; 205(1):95-101. PubMed ID: 9314969
[TBL] [Abstract][Full Text] [Related]
35. Radiation improves the distribution and uptake of liposomal doxorubicin (caelyx) in human osteosarcoma xenografts.
Davies Cde L; Lundstrøm LM; Frengen J; Eikenes L; Bruland S ØS; Kaalhus O; Hjelstuen MH; Brekken C
Cancer Res; 2004 Jan; 64(2):547-53. PubMed ID: 14744768
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer.
Allen TM; Cheng WW; Hare JI; Laginha KM
Anticancer Agents Med Chem; 2006 Nov; 6(6):513-23. PubMed ID: 17100556
[TBL] [Abstract][Full Text] [Related]
37. Hyperthermia mediated liposomal drug delivery.
Ponce AM; Vujaskovic Z; Yuan F; Needham D; Dewhirst MW
Int J Hyperthermia; 2006 May; 22(3):205-13. PubMed ID: 16754340
[TBL] [Abstract][Full Text] [Related]
38. Passive targeting of doxorubicin with polymer coated liposomes in tumor bearing rats.
Takeuchi H; Kojima H; Yamamoto H; Kawashima Y
Biol Pharm Bull; 2001 Jul; 24(7):795-9. PubMed ID: 11456120
[TBL] [Abstract][Full Text] [Related]
39. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.
Chen H; Qin Y; Zhang Q; Jiang W; Tang L; Liu J; He Q
Eur J Pharm Sci; 2011 Sep; 44(1-2):164-73. PubMed ID: 21782939
[TBL] [Abstract][Full Text] [Related]
40. Visualization of bioavailable liposomal doxorubicin using a non-perturbing confocal imaging technique.
Krishna R; Ghiu G; Mayer LD
Histol Histopathol; 2001 Jul; 16(3):693-9. PubMed ID: 11510957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
